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Abstract. We have analyzed two genetic variants of 
C2 muscle cells that have reduced levels of binding 
activity for a-bungarotoxin and have found that both 
synthesize only low levels of the a-subunit of the ace- 
tylcholine receptor.  In both variants the uptake of 22Na 
in response to carbachol is diminished in proportion to 
the reduction in toxin-binding activity. In addition,  the 
kinetic and sedimentation properties of the residual 
toxin-binding  activity in both is indistinguishable from 
that seen in wild-type cells. Immunoblotting experi- 
ments on extracts of the variants using subunit-specific 
antibodies to a- and 13-subunits of the acetylcholine 
receptor demonstrated that the 13-subunit was present, 
but failed to detect a-subunit.  In both variants,  the 
amount of a-subunit accumulated after a 5-min period 
of labeling with  [35S]methionine  was reduced by over 
90%, leading to the conclusion that the a-subunit is 
synthesized at greatly reduced rates.  Northern blot and 
S1 nuclease analysis showed no differences between 
the a-subunit mRNA in wild-type and variant cells. 
T  HB acetylcholine receptor (AChR) 1 is the major con- 
stituent of the postsynaptic  membrane in muscle cells 
and mediates the activation of muscle cells by nerves. 
Both the concentration  and location of this protein on the cell 
surface are regulated  during  muscle cell differentiation  and 
during  the formation of the neuromuscular junction (Fam- 
brough,  1979). The mechanisms  controlling  the synthesis 
and insertion in the membrane of the AChR are thus of major 
physiological  significance. 
The AChR consists of four related polypeptide chains,  in 
the ratio  a~133'~. These subunits  extend  across the mem- 
brane to form a channel  whose opening is regulated  by the 
binding  of ACh to the two a-subunits (Conti-Tronconi  and 
Raftery,  1982; Changeux  et  al.,  1984; McCarthy  et  ai., 
1986). Each of the individual polypeptides crosses the mem- 
brane several times and is thought  to contribute one trans- 
membrane  segment  to  form  the  wall  of the  ion  channel 
(Numa et al.,  1983; Claudio et al.,  1983, Finer-Moore and 
Stroud,  1984). 
Relatively little is understood about how this protein is as- 
sembled and transported to the cell surface.  Experiments  in 
an in vitro protein synthesis system have shown that each of 
the chains is derived from a larger precursor that is inserted 
into the membrane and cleaved without association with the 
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other chains  (Anderson and Blobel, 1981). The steps after 
synthesis and cleavage have been investigated for the a-sub- 
unit in BC3H-1, a nonfusing mouse muscle cell line. Merlie 
and his collaborators have used mAbs to show that, after syn- 
thesis  and  before assembly with  the other  subunits,  this 
subunit undergoes a change  in structure that  is associated 
with the acquisition  of binding  activity for a-bungarotoxin 
(a-BuTx) (Merlie and Sebbane, 1981; Merlie and Lindstrom, 
1983; Carlin et al., 1986a; Smith et al., 1987). Their experi- 
ments also suggest that posttranslational  regulation  plays a 
role in determining the amount of active receptor in BC3H-1 
muscle ceils (Olson et ai.,  1983a; Carlin et al.,  1986b). 
One experimental  approach that has been used to inves- 
tigate the assembly and insertion of complex membrane pro- 
teins is the study of genetic variants (Goldstein et al.,  1985; 
Krieger et al.,  1985). We have recently described a method 
by which genetic variants of the C2 mouse muscle cell line 
(Yaffe and Saxel,  1977) may be recognized and isolated,  and 
have described three clones that are deficient in the surface 
expression of the AChR (Black and Hall, 1985). Here we re- 
port that two of these cell lines fail to synthesize the a-sub- 
unit of the receptor at normal rates. 
Materials and Methods 
Antibodies 
Four mAbs and an antiserum against the AChR were used either to immuno- 
precipitate AChR subunits or as probes to recognize them on immunoblots. 
mAbs 35 and 61, which recognize the a-subunit, were produced from rats 
immunized with AChR from Electrophorus electricus (Tzartos et al., 1981); 
mAb 210, which also recognizes the a-subunit (Ratnam et al., 1986a),  was 
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muscle and the mouse muscle cell line BC3H-1  (Hoehschwender, S., and 
J.  Lindstrom, unpublished results); and mAb 124,  which recognizes the 
13-subunit, was derived from rats immunized with Torpedo AChR (Gullick 
and Lindstrom, 1983). mAbs 35 and 210 bind to the main immunogenic re- 
gion located on the extraceilular surface at r  of the r  and 
mAb 61 binds to a region located on the intracellular surface at r 
(Ratnam et al., 1986a, b). mAb 124 binds to an intracellular domain of the 
13-subunit (Gullick and Lindstrom, 1983; Sargent et al.,  1984). 
The antiserum was raised in rabbits immunized with AChR purified from 
denervated rat muscle by concanavalin A-Sepharose and cobra toxin affinity 
chromatography as described by Froehner et al. (1977). 
Culture Conditions 
C2 cells were cultured according to the general procedures previously de- 
scribed (Inestrosa et al.,  1983). In most experiments, cells were plated at 
a density of 4  x  103 cells/cm  2, and were maintained in a medium contain- 
ing  20%  FCS  and  0.5%  chick  embryo  extract  until  they  approached 
confluence (2-3 d). The medium was then changed to one containing 10% 
horse serum (fusion medium), and the cultures were analyzed 2-3 d later. 
The muscle cells at this time were extensively fused into myotubes and 
AChR expression was at its peak (inestrosa et al.,  1983). 
Preparation of C2 Extracts 
Myotube cultures were scraped into ice-cold buffer (extraction buffer) con- 
taming  10 mM Tris-HCl (pH 7.4)/1  mM EDTAil  mM EGTA/I%  Triton 
X-100/1 mM sodium tetrathionate/1 mM N-ethylmaleimide/0.5 mM phenyl- 
methylsulfonyl fluoride/1  mM  benzamidine/20  U  per  ml  of aprotinln/ 
20 I~g/ml of leupeptin. 1(3 ml of extraction buffer per cm  2 of culture sur- 
face were used. The cells were homogenized in a ground glass homogenizer, 
the homogenate was centrifuged for 20 min at 4"C at 25,000 g and the super- 
natant fraction was used as a crude AChR preparation. In some cases the 
myotubes were taken up and homogenized in extraction buffer without Tri- 
ton X-100, and the homogenate centrifuged for 1 h at 4~  at 138000 g in 
an SW 50.1 rotor. The pellet was then homogenized in extraction buffer, and 
insoluble material was removed by low-speed centrifugation as described 
above. Both extraction procedures gave essentially the same results in the 
experiments described below. 
Radioactive Labeling of  Myotube Proteins 
Myotube cultures in 75-cm  2 dishes were incubated either overnight or for 
5  rain  with  0.5  mCi  [~S]methionine  (5-15  Ci/mmol)  in  5-ml  fusion 
medium containing 10 IxM unlabeled methionine. After the incubation, the 
medium was removed, the cultures were rinsed once with PBS, and the cells 
were extracted as described above. 
Assays 
AChR and acetylcholinesterase assays were carried out as previously de- 
scribed (Inestrosa et al.,  1983;  Brockes and Hall,  1975). Creatine phos- 
phokinase assays were performed according to Olson et al. (1983b). Protein 
assays were performed by the method of Lowry et al.  (1951). 
Kinetics of  a-BuTx-AChR Binding 
To determine the rate of AChR-ct-BuTx association, crude extracts contain- 
ing AChR ('~500 fmol) were incubated at room temperature with 1 nM 
~I-a-BuTx in a total volume of 600 Ixl. Aliquots (80 ttl) of the reaction 
mixture were then diluted at various times into 320 Ixl ice-cold buffer con- 
taining 0.1  )xM unlabeled toxin. Toxin-receptor complex was detected by 
DEAE  filtration,  and  the  data  were  analyzed  as  previously  described 
(Brockes and  Hall,  1975). To  determine the rate of dissociation of the 
toxin-receptor complex, ,~500 fmol AChR was incubated in a total volume 
of 200 ttl with 5 nM mI-tt-BuTx for 60 rain at 37"C.  To block further for- 
marion of labeled toxin-receptor complex, unlabeled toxin was added to 
give a final concentration of 0.5 I~M. Aliquots were then taken at various 
times, and the amount of labded toxin-receptor complex determined by 
DEAE filtration. 
Sucrose Gradients 
Extracts were prepared from cultures in 25-cm  2 plates, as described above, 
and were layered on a 5-ml linear gradient of 5-20% sucrose in extraction 
buffer.  The gradients were centrifuged in an L-5 centrifuge (Beckman In- 
struments, Inc., Palo Alto, CA) at 10*C for 14 h at 116,000 g in an SW 50.1 
rotor. Fractions of 'x,0.35 ml were then collected, and each fraction assayed 
for 125I-r  binding activity by DEAE filtration. 
Affinity Purification 
An extract made from two 75-cm  2 myotube cultures was incubated for 3 h 
at 4"C with 0.3 ml of cobra toxin-Sepharose (0.3 mg/mi) prepared as de- 
scribed in Brockes and Hall (1975). The resin was then transferred to a 
column, washed twice with a 0.5-ml extraction buffer, once with 1 ml 1 M 
NaCi in extraction buffer, and once with an additional 1 ml extraction buffer. 
Three successive elutions were then carded out at 30-min intervals with 
0.15 ml 1 M carbamylcholine in extraction buffer. The elnants were com- 
bined and 40% "IV_.A  added to a final concentration of 10%. The precipitated 
protein was collected by centrifugation and dissolved in 150 ~tl of SDS- 
PAGE sample buffer (Laemmli, 1970). After addition of a few microliters 
of 1 M  NaOH to neutralize the sample, it was dialyzed twice for 4-8 h 
against 600 ml of sample buffer to reduce the ionic strength. A 40-1xl aliquot 
was then subjected to SDS-PAGE according to the procedures of Laemrnli 
(19"/0). 
Immunoprecipitations 
Myotube extracts were immunoprecipitated with mAbs 35, 210, and 124, 
and with an antiserum to denervated rat muscle AChR. For samples in im- 
munoblot experiments, 200-111 aliquots of extract were incubated for 2 h at 
4~  with an amount of primary antibody that would precipitate over 50% 
of  the r  binding activity in extracts of  wild-type cells. An IgG fraction 
of rabbit anti-rat IgG (Cappel Laboratories, Cochranville, PA) conjugated 
to protein A-Sepharose beads (Pharmacia Fine Chemicals, Piscataway, N J) 
by the method of Schneider et al. (1982) was then added and the incubation 
continued for 1 h at 4oc. The material bound to the Sepharose beads was 
washed three times with 0.5 M NaCI, 0.1% Triton X-100, 10 mM sodium 
phosphate, pH 7.4, once with 10 mM sodium phosphate, pH 7.4,  and then 
eluted in SDS-PAGE sample buffer by boiling for 4-5 rain. 
For extracts of [35S]methionine-labeled  cells,  100-1xl aliquots were in- 
cubated with 1(30 ~tl of a  10%  suspension of fixed Staphylococcus aureus 
(Calbiochem-Behring Corp., La Jolla, CA) for 15 min at 4~  and then, 
after removal of the S. aureus, with primary antibody as described above. 
When mAbs were used as the first antibody, an IgG fraction of a rabbit 
anti-rat IgG serum was then added for 60 min at 4~  followed by a 30-min 
incubation with fixed S.  aureus that had been preincubated with unlabeled 
cell extract. When the rabbit serum was used as a first antibody, preabsorbed 
S. aureus was added without prior addition of second antibody. The immu- 
noprecipitated material was then washed and processed for SDS-PAGE as 
described above. 
Immunoblots 
Each immunoprecipitated sample was divided between two gel lanes and 
subjected to  SDS-PAGE.  Proteins  in  the  gel  were  then  transferred to 
nitrocellulose and the nitrocellulose was blocked for 30 rain with 0.15 M 
NaC1, 0.3% Tween 20, 20 mM sodium phosphate, pH 7.4. The nitrocellu- 
lose was then incubated overnight in 10 ml of the blocking solution contain- 
ing either mAb 210 or mAb 124, washed four times with blocking solution, 
and incubated 2 h with 2  ￿  I(Y  f cpm of L~I-goat anti-rat IgG antibody. Fi- 
naUy, the nitrocellulose was washed four times with the blocking solution. 
Fluorography 
Gels  with  [35S]methionine-labeled  samples  were  treated  with  Enhance 
(New England Nuclear, Boston, MA) according to the manufacturer's in- 
structions, and exposed to film. Exposures were 3 d for the gels shown in 
Fig. 4, and 5 d for those shown in Fig. 5. 
$1 Nuclease Analysis 
RNA was isolated from C2 cells using the guanidine thiocyanate procedures 
of Chirgwin et al. (1979). Poly(A)  + RNA was selected by chromatography 
over an oligo (dT) cellulose column (Aviv and Leder, 1972). Hybridization 
of Poly(A)  + RNA to the eDNA encoding the mouse muscle a-subunit 
(Boulter et al., 1985) and subsequent $1 naclease digestion and analysis of 
Sl-resistant products were performed as described previously (Goldman et 
al.,  1985). 
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of  Differentiated Myotubes in WiM-Type and 
Variant C2 Cultures 
Activity  Wt  1  R-  2R- 
Creatine  phosphokinase 
(lamol/min per mg protein)  0.63  0.49  1.42 
Acetylcholinesterase 
~mol/min per mg protein)  283  515  594 
AChR (pmol/mg protein)  0.15  <0.01  <0.01 
Myoblasts (105 cells) were cultured in 25-cm  2 flasks for 2 d in growth medi- 
um and then changed  to fusion medium. 5 d after the addition of fusion medi- 
um, the cells were scraped from the dish and assays performed as described 
in Materials and Methods. Each value represents the average of two determi- 
nations. 
Results 
A screen of'~20,000 mutagenized C2 muscle cells, using the 
replica technique (Raetz et al.,  1982; Black and Hall,  1985), 
yielded two stable variant lines with decreased levels of r 
BuTx binding activity. The two variants, which were derived 
from separate screens,  were designated  1R- and 2R- to de- 
note the apparent deficiency in AChR. Toxin-binding activity 
in variant 1R-, measured either on the surface or in extracts 
of differentiated cells, ranged from 5 to 25 96 of that in wild- 
type cells,  while  activity in 2R- cultures  was consistently 
<10%.  Both  variants  fused  to  form  myotubes  in  fusion 
medium and myotubes of  both expressed approximately nor- 
mal  amounts  of  acetylcholinesterase  and  creatine  phos- 
phokinase,  two enzymes whose levels are dramatically in- 
creased  after  fusion  (Table  I).  Thus,  the  variants  are  not 
defective in overall differentiation, but have a specific defect 
in expression of r  binding activity. 
Properties of the AChR in R- Variants 
To determine whether the low level of a-BuTx binding activ- 
ity in the variants represented a correspondingly low level of 
functional AChRs, we measured the uptake of :2Na induced 
by  carbamylcholine.  In  both  variants,  carbamylcholine- 
induced 22Na uptake was reduced in proportion to the de- 
crease in toxin-binding activity (Table II), We then examined 
whether  the  low  levels  of toxin binding  that we observed 
could be due to the presence of AChR with altered properties 
rather than to a deficiency in the number of AChRs. When 
we examined the kinetics of binding of r  neither the 
association rate of the toxin-binding reaction nor the rate of 
dissociation of toxin-receptor complex was significantly al- 
Table II. Physiological Activity of  AChR in Variant 
C2 Myotubes 
AChr  Percent  2ZNa uptake  Percent 
fm  cpm 
Wt  75  100  2,560  100 
1 R-  15  20  625  24 
2R-  2.2  3  76  3 
5-d myotube cultures in 24-well culture plates were assayed for carbamyl- 
choline-stimulated 22Na uptake as described in Maricq et al. (1985). Uptake 
was measured after 20 s. AChR was assayed by binding of t251-a-BuTx as 
described in Materials and Methods. Each  value represents the average of two 
cultures. 
Figure L Identification  of AChR subunits  in C2 cells by immuno- 
blotting. Immunoblotting  of  extracts of  wild-type C2 cells or of  par- 
tially purified AChR from the extracts was carried out as described 
in Materials  and Methods. In all cases the blots were probed with 
either mAb 210 to detect the a-subunit or mAb 124 to detect [3-sub- 
unit. In lanes 1 and 7, AChR that had been purified from C2 extracts 
with a cobra toxin-affinity column (see Materials and Methods) was 
probed  with  anti-0t-antibody  or  anti-13-antibody,  respectively. 
Lanes 2 and 8 are the same except that u-BuTx was added to the 
C2 extract before affinity chromatography  to prevent the adsorption 
of receptor to the column. Lanes 3 and 9 show extracts precipitated 
with anti-a-antibody (mAb 35) and probed with anti-a- or anti- 
[3-antibodies, respectively.  Lanes 4 and 10 show extraction  buffer 
analyzed as described for lanes 3 and 9. Lanes 5 and//show ex- 
tracts precipitated  with anti-a-antibody (mAb 124), and probed 
with anti-or or anti-[3-antibodies,  respectively. Lanes 6 and 12 show 
extraction  buffer analyzed as described for lanes 5 and//. 
tered  in  variant  cells.  The  half-time  for dissociation  was 
,',d50 h for both wild-type and variant myotubes, and the as- 
sociation rate constant in all three cases was ,x,5  x  104 M -t 
S -1.  These  values  are  in  good agreement  with  those  ob- 
tained  earlier  for C-2  cells  (Gu  et  al.,  1985).  The toxin- 
binding activity in extracts of wild-type and variant cells was 
also examined by sedimentation in sucrose gradients;  in all 
cases the peak of activity occurred at 9 S (data not shown). 
The toxin-binding activity present in the variants appears to 
be  associated  with  receptors  whose  properties  resemble 
those of the wild-type AChR. We conclude that the reduced 
toxin-binding activity reflects a  reduced amount of AChR. 
Analysis of  AChR Subunits 
The r  of the AChR binds a-BuTx in the absence of 
other subunits  (Haggerty and  Froehner,  1981; Gershoni  et 
al.,  1983;  Oblas  et al.,  1983).  We therefore  examined  the 
level of this subunit in variant cells, along with the [3-subunit 
for  comparison.  Because  Y-  and  5-subunits  are  readily 
degraded in muscle cell extracts, their levels were not deter- 
mined. To detect ct- and [3-subunits, we used mAb 210, which 
is specific for the ct-subunit (Ratnam et al., 1986a), and mAb 
124, which is specific for the [3-subunit (Gullick and Lind- 
strom,  1983). When tested on immunoblots with AChR that 
was  partially  purified  from  wild-type  C2  cells  by  cobra 
toxin-affinity chromatography, each of these antibodies rec- 
ognized a single band, of ,~40 and 50 kD, respectively (Fig. 
1,  lanes  1 and  7).  Binding to both bands was eliminated  if 
the AChR was prevented from binding to the affinity column 
by incubation of the C2 extract with excess ct-BuTx (Fig.  1, 
lanes 2  and 8). 
Because extracts  of the variant cells  contain little toxin- 
binding activity, purification of receptor subunits from these 
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anti-13-mAbs (Fig. 3, lanes I  and 2). In the case of the vari- 
ants, 13-subunit was detected after immunoprecipitation with 
anti-13-antibody, but was present in reduced amounts (Fig. 
3, lanes 4 and 6).  Significantly, 13 could not be detected in 
the variants after immunoprecipitation with anti-a-antibody 
(Fig. 3, lanes 3 and 5).  The results with antibodies to both 
a- and  13-subunits  thus  indicate  that  a  drastically reduced 
amount of a-subunit that is recognized by mAb 210 is accu- 
mulated in the variant cell lines. 
Metabolic Labeling 
We attempted to detect the a-subunit in a  different way by 
metabolically labeling  the  proteins  in  C2  myotubes  with 
[35S]methionine.  After labeling the cells for  16 h,  aliquots 
of cell extracts were incubated in parallel experiments with 
two mAbs that recognize ~t-subunit (mAb 210 and mAb 35), 
one that recognizes 13-subunit (mAb 124),  and a  rabbit an- 
tiserum that was raised against purified AChR from dener- 
vated rat muscle and that recognizes principally the a-sub- 
unit.  The  immunoprecipitates  were  then  analyzed  by 
SDS-PAGE and fluorography. In extracts of wild-type cells, 
each of these antibody preparations precipitated a protein of 
~40 kD (Fig. 4, lanes 1, 4,  7, and 13). This protein, which 
Figure 2. ct-Subunit in wild-type and R- variants. Immunoblotting 
of extracts of wild-type  and variant  cells  was performed  as de- 
scribed in Materials  and Methods.  The anti-a-antibody used for 
immunoprecipitation  was mAb 35  and  the  anti-I~-antibody was 
mAb  124. In all cases  the antibody  used  as probe to detect the 
ct-subunit was mAb 210. Lane 1, extraction buffer precipitated with 
anti-a-antibody; lanes 2 and 3, wild-type extract precipitated with 
anti-ct and anti-13-antibodies, respectively; lanes 4 and 5, 1R- ex- 
tract precipitated with anti-or and anti-13-antibodies, respectively; 
lanes 6 and 7, 2R- extract precipitated with anti-or and anti-[i-anti- 
bodies,  respectively. 
cells using cobra toxin-affinity chromatography was not pos- 
sible.  It was also not possible to detect a- and I~-subunits 
reliably in immunoblots of crude extracts of either wild-type 
or variant cells. We therefore devised a procedure in which 
the subunits  were immunoprecipitated from crude extracts 
using  mAbs to  ct-  or  13-subunits.  These partially purified 
preparations were subjected to SDS gel electrophoresis and 
transferred to nitrocellulose. The immunoblots were then in- 
cubated with the mAb probe, followed by 125I-second anti- 
body. This method has the disadvantage that immunoglobu- 
lin  from  the  immunoprecipitation  is  recognized  by  the 
125I-second  antibody and forms a  strong background band 
on  the  film.  Both  ct-  and  13-subunits  were  separated  well 
enough  from  the  immunoglobulin  bands,  however,  to  be 
clearly recognized (Figs.  1 and 2). 
In extracts of wild-type cells treated by this procedure, the 
ct-subunit was precipitated both by anti-or and by anti-13- 
antibodies,  indicating that the two subunits  were part of a 
larger complex that is presumably the intact AChR (Fig. 2, 
lanes 1-3).  In the case of both variants, we detected little or 
no ct-subunit after precipitation with either antibody (Fig. 2, 
lanes 4-7). 
When the anti-13-mAb was used as the probe for immuno- 
blotting, ffsubunit could also be detected in extracts of wild- 
Figure 3. 13-Subunit in wild-type and R- variants. Immunoblotting 
of extracts of wild-type  and  variant cells  was performed  as de- 
scribed  in Materials  and Methods.  The anti-a-antibody used for 
immunoprecipitation  was mAb 35  and  the  anti-13-antibody was 
mAb  124. In all cases the  antibody  used  as probe to detect the 
13-subunit was mAb 124. Lanes 1 and 2, wild-type extract precipi- 
tated with anti-or and anti-I~-antibodies, respectively; lanes 3 and 
4,  1R- extract precipitated with anti-or and anti-13-antibodies, re- 
spectively; lanes 5 and 6, 2R- extract precipitated with anti-or and 
anti-I~-antibodies, respectively;  lane  7, extraction buffer precipi- 
tated with anti-a-antibody. 
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a-subunit from wild-type and vari- 
ant cells after long-term labeling 
with  [35S]methionine.  3  d  after 
addition  of fusion  medium,  the 
cells  were  incubated  with  [35S]- 
methionine for 16 h as described 
in  Materials  and  Methods.  Ex- 
tracts of the cells were then im- 
munoprecipitated  with  different 
antibodies  and  the  immunopre- 
cipitates  analyzed  by  SDS  gel 
electrophoresis  as  described  in 
Materials and Methods. Lanes 1- 
3,  radioactive  proteins  precipi- 
tated by the anti-a-mAb 35 from 
wild-type,  1R- and 2R- extracts, 
respectively;  lanes 4-6, proteins 
precipitated by the anti-a-mAb 210 from wild-type,  1R- and 2R- extracts; lanes 7-9, proteins precipitated by the anti-13-mAb 124 from 
wild type, IR- and 21t- extracts; lanes 10-12, proteins precipitated in the absence of first antibody from wild-type,  1R- and 2R- extracts; 
lanes 13-15, proteins precipitated by an anti-AChR antiserum from wild-type,  1R- and 2R- extracts; lanes 16-I8, proteins precipitated by 
the preimmune serum from wild-type,  1R- and 21t- extracts. 
is the a-subunit, was not seen in the absence of antibody or 
with preimmune serum (Fig. 4, lanes 10 and 16). No radio- 
active  band  at  40  kD,  or  at  any  other  position,  was 
specifically precipitated from extracts of the variant cells by 
any of the antibodies that we tested (Fig. 4, lanes 2, 3, 5, 6, 
8, 9, 14, and 15). Both the immunoblot experiments and the 
long-term metabolic labeling experiments thus show that the 
variant cells fail to accumulate significant steady-state levels 
of ct-subunit. 
In the metabolic labeling experiments, a radioactive band 
in the expected position for the 13-subunit was seen in wild- 
type, but not variant cells after immunoprecipitation with ei- 
ther anti-a-antibodies (Fig. 4, lanes 1-6) or with the serum 
(Fig. 4, lanes 13-15). Radioactivity was also seen in the 13 re- 
gion in both wild-type and variant cells after immunoprecipi- 
tation with the anti-13 antibody.  Although these results are 
consistent with the results of the immunoblots, their interpre- 
tation  is  complicated  by  the  presence  of nonspecifically 
precipitated proteins in the 50-kD region that prevent the un- 
equivocal identification of the 13-subunit in each case. 
The virtual absence of the a-subunit in long-term meta- 
bolic labeling experiments could arise from a defect in syn- 
thesis or from the rapid degradation of an altered or abnor- 
mal subunit.  To distinguish  these possibilities,  we labeled 
cells with [35S]methionine  for only 5  min and immunopre- 
cipitated the ct-subunit.  Under these conditions, the amount 
of labeled a-subunit should reflect the rate of its synthesis. 
The immunoprecipitation was carried out using either the 
anti-AChR serum described above or mAb 61,  which  has 
been shown by Merlie and Lindstrom (1983) to recognize the 
primary  transcription  product  of  the  a-subunit.  Similar 
results were obtained in both cases. In experiments with the 
serum,  labeled  a-subunit  was  immunoprecipitated  from 
wild-type cells after a  5-rain pulse of [35S]methionine  but 
little or no labeled a-subunit was detected in either variant 
(Fig. 5). Also with mAb 61, only a small amount of labeled 
subunit was immunoprecipitated from the variants (data not 
shown). In these experiments the radioactivity in the a-sub- 
unit relative to that of the contaminating actin band was com- 
pared in the three cases. The ratio of ct to the reference band 
was 0.98 in the case of wild-type and 0.05 and 0.08 in the case 
of 1R- and  2R-.  We conclude  from the  results of experi- 
ments with both the  antiserum and with mAb 61  that the 
a-subunit  is  synthesized at an abnormally low rate  in  the 
variant cells. 
Figure 5. Immunoprecipitation of a-subunit  after pulse-labeling of 
wild-type and variant cells with [sSS]methionine. The experiment 
was performed as described  in Fig. 4, except that the cells were 
labeled  for 5 min with  [aSS]methionine. Lanes 1-3, proteins pre- 
cipitated by an anti-AChR antiserum from wild-type,  1R- and 2R- 
extracts, respectively; lanes 4-6, proteins precipitated by the preim- 
mune serum from wild-type,  1R- and 2R- extracts. 
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We examined the mRNA coding for the  a-subunit  of the 
AChR in wild-type and variant cells using a probe prepared 
from a eDNA clone described by Boulter et al. (1985). This 
clone was obtained from a eDNA library prepared from the 
mouse muscle cell line,  BC3H-1  (Schubert et al.,  1977). 
When poly(A)  + RNA was extracted from myotube cultures 
of each of the three cell types and analyzed by Northern 
blots, a single band of  2 kb and of approximately equal inten- 
sity was found in each case (data not shown). 
To determine whether the mRNA coding for the ct-subunit 
in the variants was altered, we carried out an S1  nuclease 
digestion of heteroduplexes formed between the mRNA and 
regions of the eDNA clone coding for the a-subunit as de- 
scribed by Maniatis et al.  (1982).  This clone codes for the 
entire mature a-subunit and includes 26 bases coding for the 
leader peptide at its 5' end. Three fragments of this clone 
were subcloned into the single-stranded phage M13 (Messing 
and Vierra,  1982) and used for the analysis. The first con- 
tains 450 bases at the 5' end of  the clone; the second contains 
the remaining 1,770 bases at the 3' end; and the third contains 
540 bases between two Rsa I sites near the extreme 3' end 
(Fig. 6 A). 
For the analysis, mRNA prepared from wild-type cells and 
from  the  two  variants  was  hybridized to  single-stranded 
DNA from each of the subclones.  After digestion with S1 
nuclease,  the  hybrids  were  subjected  to  electrophoresis 
through denaturing polyaerylamide gels and electroblotted 
to gene-sereen plus, and the mRNA sequences surviving S1 
nuelease digestion were visualized by hybridization with a 
nick-translated probe prepared from the entire eDNA clone 
(Fig. 6 B). 
The results of these experiments showed that both variants 
made approximately normal levels of a-subunit mRNA, and 
that in each case the protected fragments seen with all three 
probes were indistinguishable from those seen with wild- 
type mRNA.  The multiple fragments protected by the 3'- 
1,770 and  Y-540 nucleotide-long probes likely reflect the 
expression of a-subunit mRNAs that use different polyade- 
nylation signal sequences (Goldman et al., 1985). Thus, the 
S1  analysis revealed no differences from the wild-type in 
a-subunit mRNA made by either of the two variants. 
Discussion 
We have attempted to define the defect in two variants of the 
C2 muscle cell line that were isolated by a replica technique 
in which intact cells were screened for a reduced amount of 
binding  of a-BuTx.  The two  variants,  1R-  and  2R-,  are 
characterized by a deficiency of toxin-binding activity, both 
in cell extracts and on the cell surface. They are similar in 
all aspects that we have investigated. Because the cells fuse 
to  form  myotubes  and  express  levels  of  ereatine  phos- 
phokinase and acetylcholinesterase that are equal to or above 
those of wild-type cells, the defect is not a simple failure of 
differentiation, but appears to be specific to the AChR. 
One possibility is that the toxin-binding function of the 
AChR is aberrant, but that the receptor is otherwise normal. 
This does not seem to be the case, as the ability of the vari- 
ants to take up 22Na was reduced in proportion to the reduc- 
tion in toxin-binding activity. Moreover, the kinetics of toxin 
Figure 6.  $1 nuclease analysis of C2 mRNAs. (A) Fragments of 
eDNA subcloned into M13 for hybridization with mRNA. (B) Gel 
profile of SI nuclease-protected fragment generated by S1 nuclease 
digestion of heteroduplexes formed between the wild-type and the 
two mutant C2 cell line mRNAs (5 ttg) with the 5'-450, 3'-1,270, 
and 3'-546 nucleotide-long subclones. 
binding associated with the residual activity is similar to that 
found in wild-type cells, as is the sedimentation constant. We 
conclude that the deficiency in toxin binding is due to a re- 
duced amount of functional receptor. 
Analysis of cell extracts of both 1R- and 2R- with sub- 
unit-specific antibodies showed that neither of the variants 
accumulated detectable amounts of the a-subunit. One pos- 
sible explanation of the failure to accumulate the a-subunit 
is the production of a polypeptide chain that is abnormally 
suceptible to proteolytic degradation.  In our experiments, 
however, the amount of labeled r  detected after a 
5-rain  pulse  with  [35S]methionine  was  reduced  by  over 
90%. Because of the short time of labeling, this decrease is 
unlikely to be due simply to an increase in the rate of a degra- 
dation. 
Our results are most easily explained by a defect in synthe- 
sis of the a-subunit or by the failure of our antibodies to 
recognize a polypeptide chain that is altered or that is not 
properly modified. The specificities of the antibodies that we 
have used makes it unlikely that an intact a-chain or any sub- 
stantial fragment of it is produced in normal amounts by the 
variant cells.  Both the serum and mAb 61,  the antibodies 
used in the short-term labeling experiments, recognize the 
a-chain produced after a 5-rain pulse with [35S]methionine 
in wild-type C2 cells. In BC3H-1 cells Merlie and his col- 
leagues have previously shown that mAb 61 recognizes the 
a-subunit after 5 min of labeling, and that this corresponds 
to a time before a  substantial fraction of the a-subunit has 
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ity on it (Merlie and Sebbane,  1981; Merlie and Lindstrom, 
1983;  Smith et al.,  1987).  mAb 61 has been also shown to 
recognize proteolytic  fragments of the  Torpedo r 
(Ratnam et al., 1986a) and forms of the 0t-subunit in BC3H-1 
cells in which the NH2-1inked sugars are altered or missing 
(Merlie et al.,  1982;  Smith et al.,  1986).  In other experi- 
ments, we used mAb 210 which recognizes a portion of the 
a-chain that is near the NH2-terminus,  between amino acid 
residues 46 and 127. This antibody binds to denatured a-sub- 
unit and to proteolytic fragments of r  on immunoblots (Rat- 
nam et al., 1986a). Finally,  we have used in experiments not 
reported here an mAb (14-3-F7)  that binds to the or-chain on 
immunoblots and that recognizes an unidentified cytoplas- 
mic portion of the a-chain (Black, R. A., A. Dowding, and 
Z. W. Hall, unpublished results). None of these antibodies 
detects a polypeptide chain made in substantial  amounts in 
the variant ceils. 
In contrast to r  the 13-chain was clearly detected in immu- 
noblots of extracts  from both variants,  although in reduced 
amounts. In quantitative radioimmunoassay experiments, the 
13-subunit in 1R- cells has been estimated to be 35 % that of 
the wild-type (LaRocheUe, W. S., S. Froehner, and Z. W. 
Hall, unpublished results). The 13-subunit in extracts  of the 
variant myotubes was not complexed with ~x-subunits, since 
it could not be precipitated by antibodies to r  These results 
are consistent with the virtual absence of an immunologi- 
cally competent a-chain in the extracts.  The lower amounts 
of 13 found in variant as compared with wild-type cells could 
result from a reduced rate of synthesis of 13 or from a greater 
susceptibility of unassembled 13-subunit to proteolytic degra- 
dation.  Because  of difficulties  in  reliably  identifying  the 
13-band in radiolabeling experiments, we did not pursue this 
question.  Whether ~,- and 8-chains are also made by these 
ceils is unknown. Because both are highly susceptible to pro- 
teolysis in extracts,  and fewer specific antibodies are avail- 
able for their detection, we did not test for their presence. 
Although a-chains were found at barely detectable levels, 
r  was present in both variants at approximately nor- 
mal  levels.  Moreover,  an  S1  analysis  using  three  mouse 
cDNA probes that covered the entire coding region for the 
r  revealed no differences between variant and wild- 
type mRNAs.  These results suggest that if there are differ- 
ences in the regions covered by the probes, they are subtle 
and probably consist of single base pair changes. Since the 
original cDNA clone lacks part of the leader sequence and 
the 5'-untranslated region, there could be differences in these 
regions between variant and wild-type mRNAs that we do 
not detect. 
What is the molecular basis of the difference between the 
variants and the wild-type cells? One possibility is that there 
is a defect in the mRNA for the r  that escaped detec- 
tion by S1 nuclease analysis. Such a defect might occur either 
in  the  coding  region  leading  to  a  truncated  polypeptide 
chain,  or in the 5'-untranslated  region leading to defective 
chain initiation. A  second, more remote possibility is that 
the defect is outside the structural gene for the ct-subunit, and 
is expressed as the absence of some function that is required 
for a-chain synthesis.  Experiments with expression vectors 
containing an intact cDNA for the ct-subunit  should distin- 
guish these possibilities. 
Whatever the cause of the defect, the availability of a mus- 
cle cell line that makes reduced amounts of ct-subunit, and 
therefore of the AChR, should be a useful tool in investigat- 
ing assembly of the receptor and construction of the special- 
ized postsynaptic membrane. 
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